TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
114 hedge funds and large institutions have $958M invested in Trillium Therapeutics Inc. in 2020 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
48% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 25
36% more funds holding
Funds holding: 84 → 114 (+30)
Holders
114
Holding in Top 10
6
Calls
$14.1M
Puts
$7.39M
Top Buyers
| 1 | +$35.5M | |
| 2 | +$30.7M | |
| 3 | +$24.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$12.8M |
Top Sellers
| 1 | -$33M | |
| 2 | -$7.57M | |
| 3 | -$4.61M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$4.34M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.14M |